SONG Yao, GUO Heng, YANG Hongge, et al. Interaction Between Cyclosporine and Statins in the Treatment of Primary Nephrotic Syndrome. [J]. (2):234-236(2023)
DOI:
SONG Yao, GUO Heng, YANG Hongge, et al. Interaction Between Cyclosporine and Statins in the Treatment of Primary Nephrotic Syndrome. [J]. (2):234-236(2023) DOI: 10.14009/j.issn.1672-2124.2023.02.022.
Interaction Between Cyclosporine and Statins in the Treatment of Primary Nephrotic Syndrome
OBJECTIVE: To investigate the application of statins in patients with primary nephrotic syndrome in this hospital
and to probe into the possible drug interactions between various types of statins and cyclosporine
so as to provide reference for rational clinical drug selection. METHODS: The application of statins in patients diagnosed with primary nephrotic syndrome in outpatient department in this hospital from Jan. to Jun. 2022 was retrospectively analyzed; the categories of statins used and their possible drug interactions with cyclosporine were compared and analyzed by using the Lexicomp drug interaction database and dispensatory. RESULTS: From Jan. to Jun. 2022
the main statins used by patients with primary nephrotic syndrome in this hospital included pravastatin
fluvastatin
simvastatin
atorvastatin and rosuvastatin; among them
simvastatin and rosuvastatin were definitely prohibited in combination with cyclosporine in the “contraindications” of the dispensatory. In the Lexicomp database
the drugs with D-class interactions with cyclosporine were pravastatin
fluvastatin and resulvastatin; the drugs with X-class interaction with cyclosporine were simvastatin and atorvastatin. CONCLUSIONS: In the treatment of primary nephrotic syndrome
there are interactions between cyclosporine and statins
and the literature reports do not fully agree with the dispensatory; physicians need to take a comprehensive consideration when making decisions
choosing pravastatin and fluvastatin may be more desirable.
Systematic Review of Efficacy and Safety of Dantian Jiangzhi Pills Combined with Statins in the Treatment of Hyperlipidemia
Effect of Different Preservation Conditions on Monitoring the Blood Concentration of Cyclosporine by Chemiluminescence Microparticle Immunoassay
Allergic Reactions Induced by Statins
New Progress and Treatment Monitoring of Lipid-Regulating Drugs
Systematic Review of Xuezhikang Capsules Combined with Statins in the Treatment of Hyperlipidemia
Related Author
WU Yang
CUI Jie
FAN Zongjing
LI Xingxing
LIU Wei
LI Dan
ZHANG Lingpeng
CHEN Jingxia
Related Institution
Second School of Clinical Medicine, Beijing University of Chinese Medicine
Dept.of Cardiology, Dongfang Hospital, Beijing University of Chinese Medicine
Dept.of Pharmacy, the First Affiliated Hospital of Naval Medical University
Dept. of Pharmacy, the First Hospital of Jilin University
Pharmacy Department of the Medical Supplies Center of the Chinese PLA General Hospital is stationed in Drug Security Room of the Seventh Medical Center